Key players in the single-cell analysis market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), BD (US), ...
Friday brought more bad news for the healthcare sector as the economic outlook darkened. The losses crossed subsectors, hitting insurers, drug developers and equipment makers. Boston Scientific, ...
Shares of Danaher Corp. DHR slipped 8.15% to $181.77 Friday, on what proved to be an all-around poor trading session for the ...
Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the new Donald Trump administration. Health care stocks can often be a solid defensive play in an uncertain economy.
DHR is poised to gain from strength in the clinical diagnostics business, the Abcam buyout and shareholder-friendly policies.